CVCO vs SRPT · P/E 23, rev $2.24B vs rev $1.13B
Cavco Industries Inc (CVCO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Cavco Industries Inc (CVCO) is a residential construction company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CVCO revenue for 2026-03-28 was $2.24B. Net income was $190.6M. Revenue was up 11.4% from 2025-03-29 to 2026-03-28. CVCO currently screens at market cap $4.23B and trailing P/E 22.9.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CVCO currently screens at market cap $4.23B and trailing P/E 22.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CVCO and SRPT stock pages for the full models.
Not investment advice.